Neogenomics (NEO) Cash from Operations (2010 - 2026)

Neogenomics (NEO) has 17 years of Cash from Operations data on file, last reported at 19959000.0 in Q2 2026.

• Quarterly Cash from Operations fell 1.82% year-over-year to 19959000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 22049000.0 (up 56.94% YoY) and the FY2025 annual result came in at 5230000.0, down 25.53% from the prior year.
• Cash from Operations grew to 19959000.0 in Q2 2026, from 8137000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 20330000.0 in Q2 2025 to a low of 29040000.0 in Q1 2022.
• A 5-year average of 2437277.78 and a median of 2616500.0 in 2022 frame the typical range for Cash from Operations.
• Annual changes were most pronounced in 2022 — Cash from Operations sank 1414.03% — and 2024, when it soared 997.42%.
• Tracing NEO's Cash from Operations over 5 years: stood at 3685000.0 in 2022, then jumped by 582.61% to 17784000.0 in 2023, then sank by 44.89% to 9800000.0 in 2024, then tumbled by 86.3% to 1343000.0 in 2025, then jumped by 1386.15% to 19959000.0 in 2026.
• The last three Cash from Operations figures came in at 19959000.0 (Q2 2026), 8137000.0 (Q1 2026), and 1343000.0 (Q4 2025), per Business Quant data.